You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate and above per the Revised International Prognostic Scoring System (IPSS-R) groups

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Community Integration Questionnaire-Revised in Lower Limb

Completed
  • Amputation
  • Validity and reliability study
  • Ankara, Turkey
    Hacettepe University
Jan 30, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)

Withdrawn
  • Myelodysplastic Syndrome (MDS)
  • (no location specified)
Jul 20, 2021

The New ICU Prognostic Score APACHE-INf

Recruiting
  • Intensive Care Unit
  • +2 more
  • Prognosis Scoring
  • Nilüfer, Bursa, Turkey
    University of Health Sciences, Bursa Sehir Training & Research H
Jul 13, 2023

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    MDS Over Time - Comparison of Treated vs Untreated Patients

    Completed
    • Myelodysplastic Syndromes
      • Vienna, Austria
        Hanusch Krankenhaus, 3.Medizinische Abteilung
      Nov 21, 2022

      Nociception Coma Scale-Revised With Personalized Stimulus

      Recruiting
      • Disorder of Consciousness
      • Nociception Coma Scale-Revised
      • Rome, Italy
        Rita Formisano
      Aug 24, 2023

      Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

      Not yet recruiting
      • Newly Diagnosed Multiple Myeloma
      • Hamburg, Germany
      • +3 more
      Dec 16, 2022

      B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

      Active, not recruiting
      • B-Cell Lymphoma
      • Non-Hodgkin Lymphoma
      • Birmingham, Alabama
      • +23 more
      Dec 2, 2022

      Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

      Recruiting
      • Chronic Myelomonocytic Leukemia
      • +5 more
      • Canakinumab
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 7, 2022

      Cardiac Rhythm Disorder, Bradycardia Trial in Worldwide (Aveir VR Leadless Pacemaker System)

      Active, not recruiting
      • Cardiac Rhythm Disorder
      • Bradycardia
      • Aveir VR Leadless Pacemaker System
      • Birmingham, Alabama
      • +52 more
      Dec 16, 2022

      Information of Coma Recovery Scale-Revised for Neurobehavioral

      Completed
      • Disorder of Consciousness
      • Rehabilitation program
      • Valencia, Spain
      • +1 more
      Apr 5, 2023

      Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

      Completed
      Has Results
      • Non-Hodgkin's Lymphoma
      • Etoposide, carboplatin, ifosfamide
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      May 23, 2022

      Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms Trial in Jackson (Prostate artery embolization)

      Recruiting
      • Benign Prostatic Hyperplasia (BPH)
      • Lower Urinary Tract Symptoms
      • Prostate artery embolization
      • Jackson, Mississippi
        University of Mississippi Medical center
      Feb 22, 2022

      Atherosclerosis Trial in Monaco (18F-Na PET Scan)

      Not yet recruiting
      • Atherosclerosis
      • 18F-Na PET Scan
      • Monaco, Monaco
        Centre Hospitalier Princesse Grace
      Aug 22, 2023

      Amyotrophic Lateral Sclerosis Trial in Phoenix, New Britain, Davie (CNM-Au8)

      No longer available
      • Amyotrophic Lateral Sclerosis
      • Phoenix, Arizona
      • +3 more
      Jun 10, 2022

      ACL Injury, ACL Sprain, ACL Tear Trial (Isoinertial training, Strength Training)

      Not yet recruiting
      • ACL Injury
      • +4 more
      • Isoinertial training
      • Strength Training
      • (no location specified)
      Sep 25, 2023

      BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS) Trial in New York, Salt Lake City (Butterfly Prostatic

      Recruiting
      • BPH (Benign Prostatic Hyperplasia)
      • Lower Urinary Tract Symptoms (LUTS)
      • Butterfly Prostatic Retraction Device
      • New York, New York
      • +1 more
      May 31, 2022

      Pre-Surgical Grading System of Asherman Syndrome

      Completed
      • Asherman Syndrome
      • Classification
      • Cairo, Egypt
        Ebtesama Hospital
      Jun 4, 2023

      MDS Trial (Hetrombopag)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • (no location specified)
      May 23, 2022

      MDS Trial in Beijing (Lenalidomide, Azacitidine)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Beijing, China
        Peking union medical college hospital
      Aug 16, 2023

      Primary Myelofibrosis Trial in Japan (Fedratinib)

      Recruiting
      • Primary Myelofibrosis
      • Suwa, Nagano, Japan
      • +25 more
      Jan 18, 2023

      Liver Failure, Acute, Hepatitis, Autoimmune, Organ Dysfunction Scores Trial in France (Corticosteroid therapy)

      Not yet recruiting
      • Liver Failure, Acute
      • +3 more
      • Corticosteroid therapy
      • Angers, France
      • +26 more
      Jul 22, 2022

      Urinary Tract Infection Trial in Taichung (Nettle and Cranberry complex capsules, Placebo(starch))

      Not yet recruiting
      • Urinary Tract Infection
      • Nettle and Cranberry complex capsules
      • Placebo(starch)
      • Taichung, Taiwan
        Chung Shan Medical University Hospital
      May 19, 2023

      MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

      Recruiting
      • Myelodysplastic Syndromes
      • +3 more
      • Luspatercept Injection [Reblozyl]
      • Alessandria, Italy
      • +22 more
      Jun 20, 2023